prescription drugs
publication date
Clinical Care
Medicare Part D Model Caps Insulin Copays at $35 a MonthBeneficiaries who use insulin and join a plan participating in the voluntary model, beginning January 2021, could see average out-of-pocket...
Strategy
What We Know — and Don't Know — About Possible Coronavirus Treatments Promoted by TrumpThere isn?t enough evidence that decades-old anti-malarial drugs work for the treatment or prevention of coronavirus, but here?s what we...
Strategy
Gilead Backtracks on Orphan Drug Designation for RemdesivirNIH is testing the antiviral drug's safety and efficacy against COVID-19.
Strategy
Doctors Are Hoarding Unproven Coronavirus Medicine by Writing Prescriptions for Themselves and Their FamiliesDemand for chloroquine and hydroxychloroquine surged over the past several days as President Donald Trump promoted them as possible treatments...
Finance
Allergan Reduces Operating Loss by 29%, Revenues Tick UpThe Dublin-based drugmaker improved on most financial metrics during 2019.
Strategy
CMS Proposes 0.93% Pay Rate Hike for MA Plans in 2021The rate hike is part of a broader package of proposed "refinements" for Medicare Advantage and the Part D Quality...
Finance
Bristol-Myers Squibb Revenues Top $26B, EPS Falls 33%The New York-based drugmaker also saw U.S. revenues rise 42% in Q4 2019.
Finance
Worldwide Sales for Merck Nearly Reach $47BThe Kenilworth, New Jersey?based drugmaker also announced plans to spin off three segments into a new company.
Finance
Pfizer Revenues Slide to End 2019The New York-based drugmaker projects its 2020 revenues will be between $48.5 billion to $50.5 billion.
Finance
FTC, NY AG Charge 'Pharma Bro' Martin Shkreli and Vyera Pharmaceuticals in Daraprim Price SchemeMartin Shkreli, nicknamed the 'pharma bro,' was sentenced to seven years in prison for securities fraud in 2018.
Clinical Care
CVS Health Targets 2020 Healthcare TrendsCVS Health and its corporate partner Aetna have launched initiatives to take on some of the most daunting challenges in...
Finance
DOJ Joins Fraud Suit Against CVS, OmnicareThe lawsuit alleges that Omnicare billed Medicare and other government-sponsored health plans for hundreds of thousands of invalid prescriptions.